Department of Ophthalmology, University Medical Center Mainz; Private Institute of Applied Ophthalmology Berlin; Department of Ophthalmology, University Hospital Cologne.
Dtsch Arztebl Int. 2020 Mar 27;117(13):225-234. doi: 10.3238/arztebl.2020.0225.
Glaucoma is a group of chronically progressive disorders of the optic nerve. In this article, we present the epidemiology of and risk factors for glaucoma, as well as the diagnostic work-up and treatment options.
This review is based on pertinent publications retrieved by a selective search in Medline and the Cochrane Library, supplemented by further articles chosen by the authors.
In Europe, the prevalence of glaucoma is 2.93% among persons aged 40 to 80 years. The prevalence rises with age, reaching 10% in persons over 90 years old. The available diagnostic methods include ophthalmoscopy, tonometry, perimetry, and imaging techniques. The treatment of glaucoma is focused on lowering the intraocular pressure with topical drugs, laser therapy, and glaucoma surgery. In patients with manifest glaucoma, lowering the intraocular pressure prevents the progression of visual field defects, with a number needed to treat of 7.
The diagnostic evaluation of glaucoma rests on multiple pillars, all of which must be considered for establishing the diagnosis and defining the desired target pressure: these are, among others, the intraocular pressure and ocular function and morphology. Individually tailored pressure-lowering treatment should be evaluated in regularly scheduled follow-up visits for assessment of function and morphology and adjusted as necessary to minimize the risk of progression.
青光眼是一组慢性进行性视神经病变。本文介绍了青光眼的流行病学和危险因素,以及诊断方法和治疗选择。
本综述基于 Medline 和 Cochrane 图书馆中通过选择性搜索获得的相关出版物,并由作者进一步选择了其他文章。
在欧洲,40 至 80 岁人群中青光眼的患病率为 2.93%。患病率随年龄增长而上升,90 岁以上人群的患病率达到 10%。现有的诊断方法包括眼底镜检查、眼压测量、视野检查和影像学技术。青光眼的治疗重点是通过局部药物、激光治疗和青光眼手术降低眼压。在有明显青光眼的患者中,降低眼压可以阻止视野缺损的进展,所需治疗数为 7。
青光眼的诊断评估基于多个支柱,所有这些都必须考虑在内,以确定诊断和定义所需的目标眼压:这些支柱包括眼压以及眼部功能和形态。应在定期的随访中评估个体化的降压治疗,以评估功能和形态,并根据需要进行调整,以最大程度地降低进展风险。